...
首页> 外文期刊>Acta biomaterialia >A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system.
【24h】

A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system.

机译:水凝胶脚手架系统中软骨细胞递送的温度固化的可溶解明胶微球基细胞载体。

获取原文
获取原文并翻译 | 示例

摘要

In this study, a novel therapeutic cell delivery methodology in the form of hydrogel encapsulating cell-laden microspheres was developed and investigated. As a model cell for cartilage tissue engineering, chondrocytes were successfully encapsulated in gelatin-based microspheres (mostly of diameter 50-100 μm, centred at 75-100 μm) with high cell viability during the formation of microspheres via a water-in-oil single emulsion process under a low temperature without any chemical treatment. These cell-laden microspheres were then encapsulated in alginate-based hydrogel constructs. By elevating the temperature to 37°C, the cell-laden microspheres were completely dissolved within 2 days, resulting in the same number of same-sized spherical cavities in hydrogel bulk, along with which the encapsulated cells were released from the microspheres and suspended inside the cavities to be cultivated for further development. In this cell delivery system, the microspheres played a dual role as both removable cell vehicles and porogens for creation of the intra-hydrogel cavities, in which the delivered cells were provided with both free living spaces and a better permeable environment. This temperature-cured dissolvable gelatin microsphere-based cell carrier (tDGMC) associating with cell-laden hydrogel scaffold was attempted and evaluated through WST-1, quantitative polymerase chain reaction, biochemical assays and various immunohistochemistry and histology stains. The results indicate that tDGMC technology can facilitate the delivery of chondrocytes, as a non-anchorage-dependent therapeutic cell, with significantly greater efficiency.
机译:在该研究中,开发并研究了包封细胞载体微球的水凝胶形式的新型治疗细胞递送方法。作为软骨组织工程的模型细胞,软骨细胞在明胶基微球中成功包封(大部分直径50-100μm,以75-100μm为中心),通过水油形成微球的高细胞活力低温下的单乳液过程无需任何化学处理。然后将这些细胞 - 载体微球包封在藻酸盐基水凝胶构建体中。通过将温度升高至37℃,细胞 - 载带微球在2天内完全溶解,导致水凝胶体积相同数量的相同尺寸的球形空腔,以及将包封的细胞从微球中释放并悬浮在其中要培养的蛀牙以进一步发展。在该细胞递送系统中,微球作为可移除的细胞载体和用于产生水凝胶内腔的孔隙的双重作用,其中提供了递送的细胞,其中包括自由生活空间和更好的渗透性环境。该温度固化的可溶解明胶微球基细胞载体(TDGMC)通过WST-1,定量聚合酶链反应,生物化学测定和各种免疫组化和组织学污渍进行了缔合的基于细胞水凝胶支架。结果表明,TDGMC技术可以促进软骨细胞作为非锚固依赖性治疗细胞的递送,效率明显更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号